Adamis Pharmaceuticals reported 16.17K in Interest Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Adamis Pharmaceuticals ADMP:US 16.17K 12.02K
Adma Biologics ADMA:US 2.27K 30.8K
Cara Therapeutics CARA:US 266K 104K
Pfizer PFE:US 30M 16M